Hemp Seed Oil.

Hemp seed oil is dominated by linoleic and alpha-linolenic acid, both of which peroxidise quickly. Tocopherol terminates the radical chain reaction and is the standard stabiliser in the oil phase.

Hemp seed oil already carries a small fraction of gamma-linolenic acid, the delta-6 desaturase product of linoleic acid. A separate GLA source adds to that and bypasses the delta-6 step that limits conversion from the parent fatty acid.

Both oils load the omega-6 side of the pathway. Linoleic and alpha-linolenic acid compete for the same delta-6 desaturase, so raising omega-6 intake lowers the share of that enzyme available to the omega-3 line.

Borage oil is the densest common GLA source and pushes the same omega-6 branch that hemp oil feeds. The two together shift the omega-6 to omega-3 ratio of the pathway substrate pool.

Both supply alpha-linolenic acid, so the doses add on the omega-3 side and improve the substrate ratio at delta-6 desaturase. Neither supplies preformed EPA or DHA.

Conversion of plant alpha-linolenic acid to EPA and DHA in humans is limited and further constrained by the oil's linoleic acid load. Preformed marine EPA and DHA cover the downstream end that hemp oil cannot reliably reach.

Delta-6 desaturase activity depends on zinc. Low zinc status slows the first and rate-limiting step in converting the fatty acids hemp oil supplies.

Cholecalciferol needs co-ingested long-chain fat to enter mixed micelles. Hemp seed oil is a suitable carrier and raises the absorbed fraction relative to a dry tablet taken without fat.

Curcuminoids are poorly water soluble and absorb better from a lipid phase. Dispersing them in a seed oil raises the amount presented to the enterocyte.

Astaxanthin partitions into the oil and across membrane lipids, where hemp oil's polyunsaturated fatty acids are most exposed to peroxidation.

Turning the linoleic and alpha-linolenic acid in hemp seed oil into longer chain fatty acids runs through the desaturase and elongase steps, and that pathway needs adequate pyridoxine along with zinc and magnesium. Short vitamin B6 status slows the conversion regardless of how much parent oil is taken. The relationship is one-directional: B6 enables the pathway, the oil supplies the substrate.

The elongation steps that extend plant omega-3 to longer chain forms consume ATP, and magnesium is required for ATP-using enzymology generally. Magnesium does not increase the oil's own content of anything; the argument is that it permits the downstream conversion. Conversion of alpha-linolenic acid stays inefficient in humans even with cofactors in place, and no trial has tested the pair.

Hemp seed oil supplies alpha-linolenic acid, the parent omega-3, and humans convert only a small fraction of it to eicosapentaenoic acid. Taking preformed EPA sidesteps the rate-limiting desaturase step entirely. The pairing covers both ends of the pathway rather than duplicating one, and neither raises the other's absorption.

Conversion of alpha-linolenic acid all the way to docosahexaenoic acid is the least efficient part of the omega-3 pathway in humans, and it is lower still in men than in women. A plant oil therefore does not substitute for preformed DHA. Supplying both means the parent fatty acid and the end product are each present.

Rosemary extract is one of the standard oxidation retardants used in polyunsaturated culinary oils, working through phenolic diterpenes that interrupt lipid peroxidation chains. Hemp seed oil is heavily polyunsaturated and oxidises readily, which is why cold pressing, dark glass and nitrogen flushing are used alongside. This is a stability pairing, not a physiological one.

Tocotrienols sit in the lipid phase and donate hydrogen to chain-carrying peroxyl radicals, the same job the tocopherols native to hemp seed oil already do. Added to a polyunsaturated oil they extend the antioxidant pool that protects the fatty acids in the bottle and in the membrane. The effect is on oxidation, which is a chemical measure and not a clinical outcome.

Phospholipid emulsifiers disperse an oil into fine droplets, which raises the surface area available to lipase and to bile salt micelles. That is why lecithin appears in emulsified and powdered oil products. It changes delivery physics, not the fatty acid profile of the oil.

Linoleic acid, the largest fatty acid fraction in hemp seed oil, is incorporated into acylceramides in the stratum corneum, so it is a substrate for barrier lipid assembly. Supplemental ceramides supply the finished lipid class instead. Substrate and product together cover the same structure from two directions, and the human data on either route is limited.

Coenzyme Q10 is a large lipophilic quinone with poor aqueous solubility, and its absorption depends on being taken with fat that triggers bile release and micelle formation. Any dietary oil, hemp included, serves that role. The oil does nothing to the molecule itself.

Xanthophylls such as lutein need lipid in the same meal to be packaged into micelles and then into chylomicrons. Co-ingestion with an oil raises measured absorption of carotenoids generally. This is an absorption effect on a blood marker, not evidence of any downstream outcome.

Menaquinone-7 is fat soluble and is absorbed through the same micellar route as other lipophilic vitamins, so it is routinely dissolved in an oil in softgel products. Hemp seed oil is one such carrier. The vitamin's activity is unchanged by which oil is used.

Medium chain triglycerides are absorbed largely by the portal route and need less bile and less chylomicron packaging than long chain fats. Blended with hemp seed oil they lower viscosity and speed the appearance of fat in circulation, but they do not carry long chain lipophiles as efficiently as long chain oils do. The two behave differently in the gut and that difference is the reason to blend, not a redundancy.

Hemp fibre, a separate fraction of the seed from the oil, has been examined for gut barrier measures after exercise in adults, and prebiotic oligosaccharides act on the same barrier through fermentation and mucin signalling. The oil itself carries no fermentable fibre. This row is a formulation hypothesis at the lowest confidence and it should not be read as evidence for the oil.